RES vs. BTCY
Compare and contrast key facts about RPC, Inc. (RES) and Biotricity, Inc. (BTCY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RES or BTCY.
Key characteristics
RES | BTCY | |
---|---|---|
YTD Return | -5.65% | -0.87% |
1Y Return | 1.76% | -69.83% |
3Y Return (Ann) | 6.63% | -55.37% |
5Y Return (Ann) | -5.05% | -23.86% |
Sharpe Ratio | 0.00 | -0.68 |
Daily Std Dev | 37.24% | 102.79% |
Max Drawdown | -92.34% | -98.77% |
Current Drawdown | -72.49% | -98.11% |
Fundamentals
RES | BTCY | |
---|---|---|
Market Cap | $1.44B | $11.60M |
EPS | $0.70 | -$1.75 |
PEG Ratio | -2.73 | 0.00 |
Revenue (TTM) | $1.52B | $11.63M |
Gross Profit (TTM) | $513.65M | $4.57M |
EBITDA (TTM) | $294.70M | -$9.23M |
Correlation
The correlation between RES and BTCY is 0.02, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
RES vs. BTCY - Performance Comparison
In the year-to-date period, RES achieves a -5.65% return, which is significantly lower than BTCY's -0.87% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
RES vs. BTCY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for RPC, Inc. (RES) and Biotricity, Inc. (BTCY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
RES vs. BTCY - Dividend Comparison
RES's dividend yield for the trailing twelve months is around 2.34%, while BTCY has not paid dividends to shareholders.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RPC, Inc. | 2.34% | 2.20% | 0.45% | 0.00% | 0.00% | 2.86% | 4.75% | 0.78% | 0.25% | 1.29% | 3.20% | 2.23% |
Biotricity, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
RES vs. BTCY - Drawdown Comparison
The maximum RES drawdown since its inception was -92.34%, smaller than the maximum BTCY drawdown of -98.77%. Use the drawdown chart below to compare losses from any high point for RES and BTCY. For additional features, visit the drawdowns tool.
Volatility
RES vs. BTCY - Volatility Comparison
The current volatility for RPC, Inc. (RES) is 11.87%, while Biotricity, Inc. (BTCY) has a volatility of 27.13%. This indicates that RES experiences smaller price fluctuations and is considered to be less risky than BTCY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
RES vs. BTCY - Financials Comparison
This section allows you to compare key financial metrics between RPC, Inc. and Biotricity, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities